What Researchers Did
Researchers conducted a meta-analysis to evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) for erectile dysfunction (ED) by reviewing studies that used the International Index of Erectile Function score.
What They Found
The meta-analysis included 5 studies and found that HBOT significantly worsened ED in patients with post-robotic-assisted laparoscopic prostatectomy-induced ED, showing a mean difference of -4.13 (95% CI, -6.08 to -2.18) favoring the control group. Conversely, patients who received HBOT for reasons other than ED exhibited an improvement in ED symptoms, with a mean difference of 4.58 (95% CI, 2.63 to 6.52).
What This Means for Canadian Patients
Canadian patients considering hyperbaric oxygen therapy (HBOT) specifically for erectile dysfunction (ED) should be aware that current evidence suggests it may not be beneficial, particularly for post-prostatectomy ED. However, if receiving HBOT for other medical conditions, some patients might incidentally experience an improvement in their ED symptoms.
Canadian Relevance
This study has no direct Canadian connection as none of the authors or institutions are identified as Canadian.
Study Limitations
A limitation of this meta-analysis is the small number of included studies (only 5), which may impact the generalizability of the findings.